By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BioWa, Inc. 

Corporate Office
212 Carnegie Center, Suite 101
Princeton  New Jersey  08540  U.S.A.
Phone: 609-580-7500 Fax: 609-919-1108


SEARCH JOBS


Industry
Biotechnology






Company News
Lonza Inc. and BioWa Sign License Agreements with FivePrime Therapeutics, Inc. for Use of Their POTELLIGENT® CHOK1SV Cell Line for Therapeutic Antibody Development 6/13/2012 10:25:54 AM
arGEN-X Announces Non-exclusive License with BioWa for Potelligent® Technology 7/26/2011 11:43:41 AM
arGEN-X Announces Non-Exclusive License With BioWa for POTELLIGENT® Technology 7/26/2011 9:43:21 AM
ImmunoCellular Therapeutics, Ltd and BioWa Announce License for the Research and Development of Therapeutic Antibodies in Cancer 6/2/2011 10:14:36 AM
Oxford BioTherapeutics Licenses BioWa's POTELLIGENT(R) Technology for the Research and Development of its Therapeutic Antibodies in Cancer 4/6/2011 7:40:13 AM
KaloBios Pharmaceuticals, Inc. Selects POTELLIGENT(R) CHOK1SV Cell Line for the Research, Development and Manufacture of Humaneered(TM) Antibodies 2/8/2011 9:06:25 AM
Daiichi Sankyo, Inc. (D4S.F) Selects POTELLIGENT(R) CHOK1SV Cell Line for the Research, Development and Manufacture of Recombinant Antibodies 7/26/2010 10:24:25 AM
BioWa Announces Expansion of Licenses to GlaxoSmithKline (GSK) 6/23/2010 10:02:25 AM
BioWa and NKT Therapeutics Inc. Announce Licensing of BioWa's POTELLIGENT(R) Technology For Use in Antibody Research and Development 10/21/2009 9:34:57 AM
BioWa Announces License of POTELLIGENT(R) Technology to Merck KGaA (MKGAF.PK) 7/15/2009 8:48:45 AM
1234
//-->